Home/Filings/4/0001104659-22-076833
4//SEC Filing

Orlinger Klaus 4

Accession 0001104659-22-076833

CIK 0001760542other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:13 PM ET

Size

5.4 KB

Accession

0001104659-22-076833

Insider Transaction Report

Form 4
Period: 2022-06-30
Orlinger Klaus
Sr. VP, Research
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-30+48,35048,350 total
    Exercise: $1.66Exp: 2032-04-19Common Stock (48,350 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother

Related Parties

1
  • filerCIK 0001768432

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:13 PM ET
Size
5.4 KB